The dopamine D_2 partial agonist is expected to reduce the positive symptoms of schizophrenia without producing movement disorders or elevated prolactin levels.

• 它可以改善精神分裂症阳性症状,而不引起运动障碍和催乳素增高,很少引起锥体外系反应。